CDKN1A and glioblastoma: In hypoxic GBM cells, 2 mM ascorbic acid increases TET2 activity by 2.3-fold, restoring 5 hmC at the CDKN1A promoter and inducing G1 arrest post-radiation (Tejero et al., 2019).